These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 22246337)

  • 21. Mutational and expression analysis of the NF1 gene argues against a role as tumor suppressor in sporadic pilocytic astrocytomas.
    Wimmer K; Eckart M; Meyer-Puttlitz B; Fonatsch C; Pietsch T
    J Neuropathol Exp Neurol; 2002 Oct; 61(10):896-902. PubMed ID: 12387455
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Malignant astrocytomas with homozygous CDKN2/p16 gene deletions have higher Ki-67 proliferation indices.
    Ono Y; Tamiya T; Ichikawa T; Kunishio K; Matsumoto K; Furuta T; Ohmoto T; Ueki K; Louis DN
    J Neuropathol Exp Neurol; 1996 Oct; 55(10):1026-31. PubMed ID: 8857999
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A/B and ATRX alterations.
    Reinhardt A; Stichel D; Schrimpf D; Sahm F; Korshunov A; Reuss DE; Koelsche C; Huang K; Wefers AK; Hovestadt V; Sill M; Gramatzki D; Felsberg J; Reifenberger G; Koch A; Thomale UW; Becker A; Hans VH; Prinz M; Staszewski O; Acker T; Dohmen H; Hartmann C; Mueller W; Tuffaha MSA; Paulus W; Heß K; Brokinkel B; Schittenhelm J; Monoranu CM; Kessler AF; Loehr M; Buslei R; Deckert M; Mawrin C; Kohlhof P; Hewer E; Olar A; Rodriguez FJ; Giannini C; NageswaraRao AA; Tabori U; Nunes NM; Weller M; Pohl U; Jaunmuktane Z; Brandner S; Unterberg A; Hänggi D; Platten M; Pfister SM; Wick W; Herold-Mende C; Jones DTW; von Deimling A; Capper D
    Acta Neuropathol; 2018 Aug; 136(2):273-291. PubMed ID: 29564591
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential expression of the tumor suppressor A-kinase anchor protein 12 in human diffuse and pilocytic astrocytomas is regulated by promoter methylation.
    Goeppert B; Schmidt CR; Geiselhart L; Dutruel C; Capper D; Renner M; Vogel MN; Zachskorn C; Zinke J; Campos B; Schmezer P; Popanda O; Wick W; Weller M; Meyermann R; Schittenhelm J; Harter PN; Simon P; Weichert W; Schirmacher P; Plass C; Mittelbronn M
    J Neuropathol Exp Neurol; 2013 Oct; 72(10):933-41. PubMed ID: 24042196
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular analysis of pediatric brain tumors identifies microRNAs in pilocytic astrocytomas that target the MAPK and NF-κB pathways.
    Jones TA; Jeyapalan JN; Forshew T; Tatevossian RG; Lawson AR; Patel SN; Doctor GT; Mumin MA; Picker SR; Phipps KP; Michalski A; Jacques TS; Sheer D
    Acta Neuropathol Commun; 2015 Dec; 3():86. PubMed ID: 26682910
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of novel genomic aberrations in anaplastic astrocytomas by GTG-banding, SKY, locus-specific FISH, and high density SNP-array.
    Holland H; Ahnert P; Koschny R; Kirsten H; Bauer M; Schober R; Meixensberger J; Fritzsch D; Krupp W
    Pathol Res Pract; 2012 Jun; 208(6):325-30. PubMed ID: 22575435
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Supratentorial pilocytic astrocytomas. A clinicopathologic, prognostic, and flow cytometric study of 51 patients.
    Forsyth PA; Shaw EG; Scheithauer BW; O'Fallon JR; Layton DD; Katzmann JA
    Cancer; 1993 Aug; 72(4):1335-42. PubMed ID: 8339223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pilocytic astrocytoma of the optic pathway: a tumour deriving from radial glia cells with a specific gene signature.
    Tchoghandjian A; Fernandez C; Colin C; El Ayachi I; Voutsinos-Porche B; Fina F; Scavarda D; Piercecchi-Marti MD; Intagliata D; Ouafik L; Fraslon-Vanhulle C; Figarella-Branger D
    Brain; 2009 Jun; 132(Pt 6):1523-35. PubMed ID: 19336457
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PTEN protein expression correlates with PTEN gene molecular changes but not with VEGF expression in astrocytomas.
    Idoate MA; Soria E; Lozano MD; Sola JJ; Panizo A; de Alava E; Manrique M; Pardo-Mindán FJ
    Diagn Mol Pathol; 2003 Sep; 12(3):160-5. PubMed ID: 12960698
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The proliferative potential of the pilocytic astrocytoma: the relation between MIB-1 labeling and clinical and neuro-radiological follow-up.
    Dirven CM; Koudstaal J; Mooij JJ; Molenaar WM
    J Neurooncol; 1998 Mar; 37(1):9-16. PubMed ID: 9525833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Absence of p53 gene mutations in a tumor panel representative of pilocytic astrocytoma diversity using a p53 functional assay.
    Ishii N; Sawamura Y; Tada M; Daub DM; Janzer RC; Meagher-Villemure M; de Tribolet N; Van Meir EG
    Int J Cancer; 1998 Jun; 76(6):797-800. PubMed ID: 9626343
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Are juvenile pilocytic astrocytomas benign tumors? A cytogenetic study in 24 cases.
    Zattara-Cannoni H; Gambarelli D; Lena G; Dufour H; Choux M; Grisoli F; Vagner-Capodano AM
    Cancer Genet Cytogenet; 1998 Jul; 104(2):157-60. PubMed ID: 9666811
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Absence of 1p/19q codeletion in oligodendroglioma-like areas of pilocytic astrocytomas.
    Frazer B; Kearney H; Cryan J; Beausang A; Brett F; Farrell MA; Buckley PG
    Clin Neuropathol; 2018; 37(4):182-185. PubMed ID: 29595124
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deletions on the long arm of chromosome 17 in pilocytic astrocytoma.
    von Deimling A; Louis DN; Menon AG; von Ammon K; Petersen I; Ellison D; Wiestler OD; Seizinger BR
    Acta Neuropathol; 1993; 86(1):81-5. PubMed ID: 8103960
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proliferative and metabolic markers in incompletely excised pediatric pilocytic astrocytomas--an assessment of 3 new variables in predicting clinical outcome.
    Margraf LR; Gargan L; Butt Y; Raghunathan N; Bowers DC
    Neuro Oncol; 2011 Jul; 13(7):767-74. PubMed ID: 21653594
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Accumulation of wild-type p53 in astrocytomas is associated with increased p21 expression.
    Ono Y; Tamiya T; Ichikawa T; Matsumoto K; Furuta T; Ohmoto T; Akiyama K; Seki S; Ueki K; Louis DN
    Acta Neuropathol; 1997 Jul; 94(1):21-7. PubMed ID: 9224526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Magnetic resonance imaging and spectroscopy of pilomyxoid astrocytomas: case reports and comparison with pilocytic astrocytomas.
    Morales H; Kwock L; Castillo M
    J Comput Assist Tomogr; 2007; 31(5):682-7. PubMed ID: 17895777
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Altered expression of immune defense genes in pilocytic astrocytomas.
    Huang H; Hara A; Homma T; Yonekawa Y; Ohgaki H
    J Neuropathol Exp Neurol; 2005 Oct; 64(10):891-901. PubMed ID: 16215461
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlative immunohistochemistry and molecular genetic study of the inactivation of the p16INK4A genes in astrocytomas.
    Rao LS; Miller DC; Newcomb EW
    Diagn Mol Pathol; 1997 Apr; 6(2):115-22. PubMed ID: 9098651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.